Binaphthyl-Based Dicationic Peptoids with Therapeutic Potential (pages 537–540)John B. Bremner, Paul A. Keller, Stephen G. Pyne, Timothy P. Boyle, Zinka Brkic, Dorothy M. David, Adel Garas, Jody Morgan, Mark Robertson, Kittiya Somphol, Michael H. Miller, Adam S. Howe, Paul Ambrose, Sujata Bhavnani, Thomas R. Fritsche, Douglas J. Biedenbach, Ronald N. Jones, Robert W. Buckheit Jr., Karen M. Watson, Dean Baylis, Jonathan A. Coates, John Deadman, Dharshini Jeevarajah, Andrea McCracken and David I. Rhodes
Article first published online: 11 DEC 2009 | DOI: 10.1002/anie.200904392

Superbugs stalled! Two newly designed synthetic dicationic peptoids (see one example; red O, blue N, green Cl) show promising in vitro bactericidal activity against a range of Gram-positive pathogens, including organisms resistant to vancomycin, methicillin, and linezolid, with only slow development of resistance. Moreover their potency is maintained in vivo.